WBCIL is an innovative manufacturer of liposomal phospholipid-based excipients and is exploring potential therapeutic benefits of liposomal excipients
Journal of Molecular Medicine , 95 (3), 323333
These studies are mechanistically aligned with the VEGFR2/eNOS in vitro findings but rely on the same originating laboratory and rodent model system, and independent replication outside that network is sparse
When Qu was added to the microneedle, the microneedle patch became yellow, and when ZC-MSN or Qu-loaded ZC-MSN was added to the microneedle, the microneedle patch became black (Fig
These have no evidence for working, dont make sense from a scientific perspective and likely will kill someone by inducing cancer or liver failure, Christin Glorioso, a physician and neuroscientist, wrote about follistatin and other unregulated gene therapies in her longevity and health newsletter